Protected: PBS listing for BRAFTOVI® (encorafenib) + cetuximab for metastatic colorectal (bowel) cancer patients with a BRAFV600 mutation(1)
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Pierre Fabre
Protected: PBS listing for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) combination therapy for adults with unresectable malignant BRAF-mutant melanoma [1]
This content is password-protected. To view it, please enter the password below. Password: